Matt Robinson

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

Development of a decision support system for monitoring, reporting and forecasting ecological conditions of the appalachian trail

Ramakrishna R. Nemani, Yeqiao Wang, Matt Robinson, 2010, 2010 IEEE International Geoscience and Remote Sensing Symposium.